Targeting the ERK2 Signaling Pathway With Frog Skin‐Derived Bioactive Peptides: Insights From Molecular Modeling, Molecular Dynamics, and Physicochemical Features
ChemistryOpen · 2026
DOI: 10.1002/open.70295 ↗Kurz gefasst
Fachartikel in der Zeitschrift ChemistryOpen, 2026. Verfasst von Nahlah Makki Almansour und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biology, College of Science, University of Hafr Al Batin, Hafar Al Batin, Saudi Arabia. Hauptthemen laut MEDLINE: Mitogen-Activated Protein Kinase 1, Skin, Peptides, Amphibian Proteins. Die Arbeit nennt 77 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Deputyship for Research & Innovation, Ministry of Education, in Saudi Arabia.
Abstract (Originalsprache)
ERK2 plays a vital function in promoting cell survival and proliferation by phosphorylating various substrates. ERK2 is a key druggable target owing to its function in uncontrolled cell proliferation and cancer, making selective ERK2 inhibitors essential for treating aggressive malignancies. Peptides are promising therapeutic agents with strong biological activity, and frog skin‐derived peptides have shown notable anticancer potential. Seventeen curated frog skin‐derived anticancer peptides were modeled and docked against the ERK2 D‐recruitment site (DRS) using HADDOCK2.4 software. The predicted peptide‐DRS complexes were introduced to molecular dynamics simulations (MDS), and their binding energies (Δ G binding ) were evaluated utilizing the MM/GBSA approach. Upon MM/GBSA//200 ns MDS, dermaseptin‐B3, dermaseptin‐PD‐1, and ascaphin‐8 showed better binding affinities against ERK2 DRS, with Δ G binding values of −77.8, −74.1, and −56.7 kcal/mol, respectively, compared with the structurally resolved DRS‐binding reference peptide KIM‐MAP3 (Δ G binding = −51.5 kcal/mol). Post‐MD analyses, including binding energy per trajectory and RMSD analyses, affirmed the great stability of the identified peptides complexed with ERK2 DRS over 200 ns MDS. The predicted physicochemical features of the identified peptides indicated favorable functional potential. Collectively, these computational outcomes highlighted dermaseptin‐B3, dermaseptin‐PD‐1, and ascaphin‐8 as promising ERK2 DRS‐binding candidates. Further experimental validation is required to confirm their functional inhibitory activity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biology, College of Science, University of Hafr Al Batin, Hafar Al Batin, Saudi Arabia.
- Computational Chemistry Laboratory, Chemistry Department, Faculty of Science, Minia University, Minia, Egypt.
- Department of Clinical Laboratory Sciences, College of Applied Medical Sciences, University of Hafr Al Batin, Hafar Al Batin, Saudi Arabia.
- Department of Supportive Requirements, University of Technology and Applied Sciences, Nizwa, Sultanate of Oman.
- School of Health Sciences, University of KwaZulu-Natal, Durban, South Africa.
ORCID-Profile: Nahlah Makki Almansour, Mahmoud A A Ibrahim
Förderung
- Deputyship for Research & Innovation, Ministry of Education, in Saudi Arabia
Zitieren
APA
Almansour, N. M., Abdelhamid, M. M. H., Alali, Z., & Ibrahim, M. A. A. (2026). Targeting the ERK2 Signaling Pathway With Frog Skin‐Derived Bioactive Peptides: Insights From Molecular Modeling, Molecular Dynamics, and Physicochemical Features. ChemistryOpen. https://doi.org/10.1002/open.70295
Vancouver
Almansour NM, Abdelhamid MMH, Alali Z, Ibrahim MAA. Targeting the ERK2 Signaling Pathway With Frog Skin‐Derived Bioactive Peptides: Insights From Molecular Modeling, Molecular Dynamics, and Physicochemical Features. ChemistryOpen. 2026. doi:10.1002/open.70295
BibTeX
@article{Almansour2026,
author = {Almansour, Nahlah Makki and Abdelhamid, Mahmoud M H and Alali, Zahraa and Ibrahim, Mahmoud A A},
title = {Targeting the ERK2 Signaling Pathway With Frog Skin‐Derived Bioactive Peptides: Insights From Molecular Modeling, Molecular Dynamics, and Physicochemical Features},
journal = {ChemistryOpen},
year = {2026},
doi = {10.1002/open.70295}
}
EUVIMED